BioNexus Gene Lab Corp (BGLC)
0.52
-0.02
(-4.41%)
USD |
NASDAQ |
May 24, 16:00
0.52
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Total Liabilities (Quarterly): 1.817M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.817M |
| December 31, 2023 | 1.742M |
| September 30, 2023 | 1.778M |
| June 30, 2023 | 1.935M |
| March 31, 2023 | 1.630M |
| December 31, 2022 | 2.075M |
| September 30, 2022 | 1.375M |
| June 30, 2022 | 1.547M |
| March 31, 2022 | 2.047M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.395M |
| September 30, 2021 | 2.713M |
| June 30, 2021 | 2.635M |
| March 31, 2021 | 3.106M |
| December 31, 2020 | 3.453M |
| September 30, 2020 | 0.0816M |
| June 30, 2020 | 0.0906M |
| March 31, 2020 | 0.0942M |
| December 31, 2019 | 0.1089M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0816M
Minimum
Sep 2020
3.453M
Maximum
Dec 2020
1.701M
Average
1.798M
Median
Total Liabilities (Quarterly) Benchmarks
| Balchem Corp | 509.91M |
| Friedman Industries Inc | 106.21M |
| Solitario Resources Corp | 0.412M |
| Golden Minerals Co | 10.73M |
| Paramount Gold Nevada Corp | 20.35M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.16M |
| Shareholders Equity (Quarterly) | 9.344M |
| Current Ratio | 4.606 |